Recall Record

Ann Arbor, MI, United States

Terumo Cardiovascular Systems Corporation recalls

23 recalls recorded since 2018, most recently on 28 May 2025. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls23
Ongoing (FDA)4
Terminated or completed19
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
28 May 2025
Reason
Due to an error in assembly of the thermistor within some units, the affected probes will experience inaccuracy in measured shunt sensor temperature. Additionally, following changes in patient temperature without an in vivo recalibration, affected probes may experience inaccuracy in other measured parameters, including pCO2, pO2, pH, Potassium and calculated parameters, including BE, Bicarbonate, Arterial Oxygen Saturation, Delivered Oxygen, Area Under of the Curve of Delivered Oxygen, Oxygen Consumption, and Oxygen Extraction Ratio, which utilize temperature as an input. Inaccurate data may lead to inappropriate user response.
Distribution
US Nationwide distribution in the states of California, Delaware, Hawaii, Iowa, Indiana, Michigan, North Carolina, New York, Ohio, and Washington. The country of New Zealand.
Initiated
Voluntary: Firm initiated
Recall number
Z-2018-2025

Ongoing Class II Medical devices

Recall started
3 March 2025
Reason
During some clinical cases, it has been observed that the SO2 value may periodically appear as dashes on the Touchscreen Display indicating unavailable data. In these cases, a yellow low-limit alarm will also be triggered to the user, due to the dashed-out value.
Distribution
US: IL, TX, NY, MI, FL, NV, and Australia, New Zealand
Initiated
Voluntary: Firm initiated
Recall number
Z-1492-2025

Ongoing Class II Medical devices

Recall started
20 February 2024
Reason
Pressure relief valve included in certain lots of cardiovascular procedure kits was reportedly opening at approximately 200-300mmHg versus 400mmHg, potential myocardial tissue damage potentially requiring surgical or medical/pharmacological intervention
Distribution
worldwide distribution - US Nationwide and the countries of Canada, Chile, Colombia, Mexico, South Korea, Taiwan, Thailand.
Initiated
Voluntary: Firm initiated
Recall number
Z-1401-2024

Ongoing Class II Medical devices

Recall started
1 March 2023
Reason
Some Capiox NX, RX and FX Oxygenators may contain an arterial thermistor component that is improperly bonded to the oxygenator port. This may result in a leak at the point where the arterial thermistor is improperly bonded to the oxygenator port.
Distribution
US Nationwide. Belgium, Canada, Costa Rica, Thailand.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1346-2023, Z-1347-2023, Z-1345-2023

Terminated Class II Medical devices

Recall started
3 February 2022
Terminated
20 February 2024
Reason
Potential for Cardiovascular Procedure Kit packaging damage that occurred during shipping.
Distribution
US Nationwide distribution in the states of CA and IN.
Initiated
Voluntary: Firm initiated
Recall number
Z-0949-2022

Terminated Class II Medical devices

Recall started
8 June 2021
Terminated
28 June 2022
Reason
intermittent failure causes a blender initialization fault upon start-up, or during an EPGS calibration attempt following the 15-minute warm-up period. The control sliders on the Central Control Monitor (CCM) are disabled and the gas system can only be controlled by the local control knobs
Distribution
International distribution in the country of Panama.
Initiated
Voluntary: Firm initiated
Recall number
Z-2350-2021

Terminated Class II Medical devices

Recall started
16 April 2021
Terminated
29 November 2023
Reason
Terumo CVS has been unable to validate a cleaning protocol to satisfy current regulatory concerns and expectations. As a result, an updated cleaning protocol will not be developed by Terumo CVS and it has been determined that the best course of action is for users to discontinue use of and dispose of HX2, TCM I and TCM II devices.
Distribution
Domestic: Foreign: Australia, Belgium, Canada, Chile, China, Colombia, Dominican Republic, England, France, Germany, Greece, Hong Kong, India, Indonesia, Iran, Israel, Italy, Japan, Korea, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Russia, Saudi Arabia, Singapore, South Korea,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1791-2021, Z-1790-2021, Z-1789-2021

Terminated Class II Medical devices

Recall started
2 March 2021
Terminated
5 November 2021
Reason
There is a potential for the stainless steel locking plates on the device's sternal retractor locking mechanism to fracture.
Distribution
US Nationwide distribution in the states of NH, WI, NJ, PA, NV, MD, TN, PA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1367-2021

Terminated Class II Medical devices

Recall started
11 November 2020
Terminated
22 November 2021
Reason
Capiox FX25 Advance oxygenator may be the incorrect configuration (East vs. West)
Distribution
US Nationwide Foreign: Belgium, India
Initiated
Voluntary: Firm initiated
Recall number
Z-0565-2021

Terminated Class II Medical devices

Recall started
25 August 2020
Terminated
29 January 2021
Reason
Internal testing at the supplier, revealed that a crimped wire was placed into an air bubble detector (ABD) sensor connector backwards, preventing the crimped wire from locking into the mating wire connector. This intermittent connection may result in false air bubble alarms.
Distribution
Worldwide distribution - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2961-2020, Z-2959-2020, Z-2960-2020

Terminated Class II Medical devices

Recall started
10 January 2020
Terminated
12 May 2020
Reason
These roller pumps were assembled with pump shafts that may fail at the location of the thread where a locknut is installed. The failure is associated with a noise that is atypical of roller pump operation. The noise is caused when an unsecured shaft end contacts the rotating pulley of the roller pump. Prolonged use of a roller pump in this condition could lead to an eventual pump stop, resulting in the inability to create pump flow due to pulley loosening and drive belt damage.
Distribution
Worldwide distribution - US Nationwide distribution in the states of CT, FL, LA, MA, MI, NY, and TX. Countries of Hong Kong, India, South Korea, and Taiwan.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1111-2020, Z-1108-2020, Z-1110-2020, Z-1109-2020

Terminated Class II Medical devices

Recall started
14 June 2019
Terminated
11 June 2020
Reason
Capiox NX19 Oxygenator may contain a non-functioning arterial thermistor component
Distribution
MI Foreign: Japan, Belgium
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2101-2019, Z-2104-2019, Z-2102-2019, Z-2103-2019

Terminated Class II Medical devices

Recall started
18 April 2019
Terminated
20 May 2020
Reason
The gas flow rate output of the EPGS may be inaccurate due to a defect in the internal flowmeter.
Distribution
Worldwide Distribution: US (nationwide) and countries of: Australia, Belgium, Canada, Chile, Hong Kong, Indonesia, Japan, Mexico, Philippines, Singapore, South Korea, Taiwan, Thailand, and United Arab Emirates.
Initiated
Voluntary: Firm initiated
Recall number
Z-1337-2019

Terminated Class II Medical devices

Recall started
20 December 2018
Terminated
20 August 2019
Reason
Presence of natural rubber latex is not declared in the label
Distribution
TX
Initiated
Voluntary: Firm initiated
Recall number
Z-0966-2019

Terminated Class II Medical devices

Recall started
17 October 2018
Terminated
30 April 2020
Reason
An intermittent failure which causes a blender initialization fault upon start-up or during an EPGS calibration attempt leads to the Central Control Monitor control sliders being disabled, such that the gas system can only be controlled by the local control knobs.
Distribution
Distribution US nationwide, including CA, CT, IL, IN, KY, MI, MN, MO, MT, NM, NY, OH, and WI. Foreign distribution to Canada, Mexico, and South Korea.
Initiated
Voluntary: Firm initiated
Recall number
Z-1769-2019

Terminated Class II Medical devices

Recall started
13 September 2018
Terminated
18 November 2019
Reason
The service manual was not updated at the time of the release of software version 1.30.
Distribution
US Nationwide in the states of: AL, AZ, CA, CO, CT, FL, GA, IL, IN, KS, KY, MI, MN, MO, OH, OR, PA, SC, TN, TX, WA, WI, and Puerto Rico. The products were distributed to the following foreign countries: Antioquia, Australia, Bangkok, Bangladesh, Belgium, Canada, Chile, China, Columbia, Dominican
Initiated
Voluntary: Firm initiated
Recall number
Z-0176-2019

Terminated Class II Medical devices

Recall started
31 August 2018
Terminated
21 October 2019
Reason
The system's IFU contains a list of generators that the have been deemed compatible. Recent reports indicate that one energy platform is not compatible with the system. Therefore, it has been removed from the list of compatible generators within the IFU.
Distribution
Worldwide - US Nationwide in the states of FL, IL, NY, OH, TX. The products were distributed to the following foreign country: Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-0227-2019

Terminated Class II Medical devices

Recall started
28 August 2018
Terminated
23 April 2020
Reason
Screws on a Terumo¿ Advanced Perfusion System 1 Power Manager Board (the base unit circuit board) were not torqued to specification. It is possible that a screw which has not been properly torqued can go undetected during manufacturing testing and may loosen over time, resulting in the potential for an electrical short in the system
Distribution
Nationwide Foreign: Mexico, BELGIUM, CANADA, India, Indonesia, Singapore, South Korea , Vietnam
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3243-2018, Z-3242-2018

Terminated Class II Medical devices

Recall started
26 June 2018
Terminated
17 April 2020
Reason
H/Sat Hybrid Intensity Shift has been seen in a subset of the H/Sat population, which has resulted in an increase of Hybrids failing the H/Sat Color Chip Test which is an automated self-test when the device is powered on. This will not result in device inaccuracy, only Color Chip Test Failure which disables the H/Sat module.
Distribution
Worldwide Distribution - US Nationwide in the states of AL, AZ, CA, FL, GA, IL, KY, LA, MA, MD, MI, MN, MO, MS, NC, NM, NY, OH, SC, TN, TX, WA, and WV. Foreign distribution to Middle East, Latin America, Europe, Japan, Canada, and Mexico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2750-2018, Z-2751-2018

Terminated Class II Medical devices

Recall started
16 March 2018
Terminated
10 June 2020
Reason
Update to cooler-heater cleaning instructions.
Distribution
Worldwide Distribution: US (Nationwide), Australia, Belgium, Canada, Chile, China. Colombia, Dominican Republic, England, Finland, France, Germany, Greece, HK, India, Indonesia, Iran. Israel, Italy, Japan, Korea, Mexico, Netherlands, New Zealand, Norway, Philippines, Russia, Saudi Arabia, Singapore,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1418-2018, Z-1417-2018, Z-1416-2018

Terminated Class II Medical devices

Recall started
19 January 2018
Terminated
18 July 2018
Reason
Inaccurrate flow readings. Depending on the degree of inaccuracy, this issue may not be easy for the user to detect during setup or use (for example, following a Flow Probe relocation or manipulation).
Distribution
Worldwide Distribution -- USA, including the states of IL, KY, and MI; and, the country of Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-1478-2018

Terminated Class II Medical devices

Recall started
18 December 2017
Terminated
9 April 2019
Reason
Possible blood leaks through the hydrophobic portion of the Pall LG6NS LeukoGuard Leukocyte Reduction Arterial Blood Filters.
Distribution
US Distribution to the states of : AL, OH, VA, NC, GA, NY, FL
Initiated
Voluntary: Firm initiated
Recall number
Z-1314-2018

Terminated Class II Medical devices

Recall started
12 May 2017
Terminated
26 October 2018
Reason
Kit was labeled with the incorrect Expiration Date of April 30, 2019.
Distribution
US state of FL
Initiated
Voluntary: Firm initiated
Recall number
Z-2550-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.